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Abstract
The Hausman (1978) test is based on the vector of differences of two esti-
mators. It is usually assumed that one of the estimators is fully efficient, since
this simplifies calculation of the test statistic. However, this assumption limits
the applicability of the test, since widely used estimators such as the generalized
method of moments (GMM) or quasi maximum likelihood (QML) are often not
fully efficient. This paper shows that the test may easily be implemented, using
well-known methods, when neither estimator is efficient. To illustrate, we present
both simulation results as well as empirical results for utilization of health care
services.
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1 Introduction
The Hausman test (Hausman, 1978) is based on the idea that the difference between
two consistent estimators tends to zero. One of the estimators, say ˆθ1, is consistent
under the null of correct specification, but inconsistent under the alternative. The other
estimator, say ˆθ2, is consistent under both the null and the alternative hypotheses.
Under the alternative hypothesis of misspecification, ˆθ1 will no longer be consistent,
but ˆθ2 will remain so. In this case the difference vector ∆   ˆθ2  ˆθ1 will have a nonzero
probability limit, which will cause the test statistic to ultimately reject the null of
correct specification.
Hausman’s paper, and most subsequent research, has concentrated on the case that
ˆθ1 is fully efficient when the associated model is correctly specified. In this case,
the asymptotic variance of ∆, V∆, is simply the asymptotic variance of the inefficient
estimator minus that of the efficient estimator. With this simplification, the test is easily
implemented using consistent estimators of the two asymptotic variances.
This paper addresses the case where neither of the two estimators is fully efficient.
For the purposes of this paper, it bears emphasizing that widely used estimators such
as quasi maximum likelihood (QML) and the generalized method of moments (GMM)
are not fully efficient, in general. When performing a Hausman test comparing two
inefficient estimators, V∆ will involve the asymptotic covariance of the estimators. It
will not cancel out as in the case analyzed by Hausman.
Some previous research has examined special cases of pairs of inefficient estima-
tors. Ruud (1984) considers the case where a likelihood function may be factored as
the sum of two likelihoods. The obvious example is a split sample. When observations
are independent, the sample may be split into two equal parts, and each part may be
used separately to calculate the two estimators. Sample splitting leads to an impor-
tant loss of power, since the asymptotic variances of the estimators are twice as large
as when the full sample is used. Nor is it a general solution, since it will not solve
the problem of correlation between the estimators when the observations are not in-
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dependent of one another. The idea of sample splitting has been further pursued in
the context of QML estimation by de Luna and Johansson (2001). Newey (1985) also
presents Hausman tests based on inefficient estimators. He considers GMM estimators
defined by different linear combinations of a given vector of moment conditions. The
major limitation of these authors’ results is that their frameworks are very specific and
are highly restrictive in terms of the pairs of estimators that may be considered.
In the empirical literature, Windmeijer and Santos Silva (1997) perform a Haus-
man test based on Poisson QML and GMM estimators. Since neither the QML nor
the GMM estimator is efficient, the authors use a split sample Hausman test, following
Ruud (1984) and Browning and Meghir (1991). In their application, Windmeijer and
Santos Silva find that this version of the test does not reject exogeneity. One wonders
whether the reason for non-rejection might be the loss of power entailed by splitting
the sample.
This paper re-examines the Hausman test when neither estimator is efficient. We
find that the standard full sample Hausman test is simple to apply in the general case,
since accounting for the covariance of the estimators is not at all difficult, and may be
done using standard methods. The result is simple, but it appears to have been over-
looked, and it does have practical importance. The result also immediately suggests
some closely related tests. Simulation results are provided that show that the standard
Hausman test may be misleading when it is calculated using a pair of inefficient es-
timators, and that the modified test performs properly under the same circumstances.
We apply the test to data on demand for health care visits and private health care in-
surance. We find strong evidence that health care insurance is an endogenous variable
in explaining demand for certain forms of health care.
In the next section we present the main results of the paper. The third section
presents the simulation results and the fourth section contains the empirical results.
3
2 Theory
Hausman (1978) recognized from the beginning that the essential problem in basing a
test on estimators that may not be efficient is that the covariance between the estima-
tors must be estimated. In this section we show that methods that have since become
standard allow this covariance to be estimated without difficulty. The argument is a
straightforward application of existing results on extremum estimators, so results are
stated without proof or explicit regularity assumptions. Gallant (1987), Chapter 3, for
example, gives regularity conditions and formal proofs of the results that are used here.
Newey and West (1987a) and Davidson and MacKinnon (1993, pp. 616-619) present
results that are suggestive of those presented here, but which do not explicitly discuss
the Hausman test.
An extremum estimator ψˆ may be defined as
ψˆ   arg max
ψ   Ψ
sn

ψ  Zn  
where Zn is the data. Extremum estimators encompass minimum distance estimators,
defined in terms of
sn

ψ  Zn   
1
n
n
∑
t  1
st

ψ  zt  
where zt is the data for one observation, and method of moments estimators, defined
in terms of
sn

ψ  Zn    mn

ψ  Zn  Wnmn

ψ  Zn  
where Eψmn

ψ  Zn    0 and Wn is a matrix with a finite, positive definite almost sure
limit. An extremum estimator will, given some regularity conditions, have an almost
sure limit, say ψ0, and will be asymptotically normally distributed:

n

ψˆ  ψ0  d N 	 0  V∞ 

where V∞   J∞

ψ0  1I∞

ψ0  J∞

ψ0  1. Here, J∞

ψ0  is the almost sure limit of
4
Jn

ψ0    ∂
2
∂ψ∂ψ   sn

ψ


ψ0 , and I∞

ψ0    limn  ∞ Var

ngn

ψ0  , where we use the nota-
tion gn

ψ0    ∂∂ψ sn

ψ


ψ0 .
To test a hypothesis of the form H0 : Rψ0   0  q  1  , the Wald statistic
W   nψˆ

R


R VR
	
 Rψˆ  (1)
where V is a consistent estimator of V∞, is asymptotically distributed as a χ2

r

random
variable, where r is the rank of RV∞R

.
Now, turning to the Hausman test, we assume that both estimators are extremum
estimators, defined by
ˆθ1 
 argmax
θ   Θ
s1n

θ  Zn  (2)
ˆθ2 
 argmax
θ   Θ
s2n

θ  Zn   (3)
where Θ  ℜk  If we define ψ   θ
1 θ 2 
 Θ  Θ, it is clear that the omnibus
estimator
ψˆ


arg max
ψ   Θ  Θ
sn

ψ

  s1n

θ1  Zn  s2n

θ2  Zn  (4)
will lead to the same values for the estimators as in equations 2 and 3. That is, ψˆ



ˆθ
1 
ˆθ
2   . It bears noting that the omnibus estimator is an extremum estimator, and the
theory reviewed above will apply, given regularity conditions. Define ψ0  

θ
A  θ 0  
as the almost sure limit of ψˆ. Under the null hypothesis of correct specification, so
that both estimators are consistent,  θA  θ0    0, so Rψ0   0  k  1  . When the first
estimator is inconsistent due to misspecification,  θA  θ0   0.
Now, if the dimension of θ is k, say, then we can define the matrix
R  ﬀ Ik  Ik ﬁ
 (5)
When ˆθ1 is asymptotically efficient, the Wald test, in equation 1, of the restriction
Rψ   0 is asymptotically equal to the standard Hausman test, and it is the Hausman
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test if the variance estimator that is used, ˆV , incorporates the information that ˆθ1 is
efficient.1 The advantage of putting the problem into the framework of extremum
estimation is that it is immediately clear how a Hausman-type test may be performed
when neither of the estimators is fully efficient. Since the two sub-objective functions
that define the omnibus estimator share no parameters, the Hessian matrix J∞

ψ0 
is simply the block-diagonal matrix formed by the limiting Hessians of the separate
estimators defined by equations 2 and 3:
J∞

ψ0    
J1
∞

θA  0k  k
0k  k J2∞

θ0 



These components may be estimated as usual. The matrix I∞

ψ0  may be written as
I∞

ψ0    
I1
∞

θA  I12∞

ψ0 
 I2
∞

θ0 



Without full efficiency of the first estimator, the off-diagonal covariance term will not
cancel out of the test statistics as it does in the standard case, and it will be necessary
to define a consistent estimator. While the on-diagonal blocks may be estimated by
whatever means are appropriate given the way the estimators are defined, we will
discuss means of estimating the entire matrix.
Recall that
I∞

ψ0    lim
n  ∞
Var

ngn

ψ0 
  lim
n  ∞
nE 	 gn

ψ0  gn

ψ0  
  lim
n  ∞
nE  gn

ψ0  E 	 gn

ψ0  



A∞

ψ0   B∞

ψ0  
In general, it is not possible to estimate B∞

ψ0  consistently. However, it is commonly
the case that B∞

ψ0    0. For example, this will hold for a minimum distance estimator
1The asymptotic efficiency of ˆθ1 implies that the asymptotic covariance between ˆθ1 and ˆθ2 is equal
to the asymptotic variance of ˆθ1 (see Hausman, 1978, Lemma 2.1) . This is what causes the asymptotic
covariance to cancel out of the formula for the standard Hausman test.
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if Eψgt

ψ

  E

Dψst

ψ

  0   t. This will be the case for QML estimators when the
data are independently and identically distributed, for example. It also holds for a
method of moments estimator if the moment conditions are of the form mn

ψ  Zn   
1
n ∑nt  1 mt

ψ  zt  and Eψmt

ψ  zt    0   t. We will assume henceforth that we are in a
situation such that B∞

ψ0    0.
With this, for minimum distance estimators,
I∞

ψ0    lim
n  ∞
Var 1
n
∑
t
gt

ψ0  
 Ω∞

ψ0  
and for method of moments estimations,
I∞

ψ0    lim
n  ∞
Var

2Mn

ψ0  Wn
1

n
∑mt  ψ0 


4M∞

ψ0  W∞Ξ∞

ψ0  W∞M∞

ψ0   
where Mn

ψ

  Dψmn

ψ


, M∞

ψ0  is its almost sure limit, evaluated at ψ0, and
Ξ∞

ψ0    lim
n  ∞
Var
1

n
∑
t
mt

ψ0   (6)
The remaining problem, as the case may be, is the estimation of Ω∞

ψ0  or Ξ∞

ψ0  .
These matrices are the asymptotic covariances of vector valued processes. A number
of estimators are available. With dependent observations, the estimators of Newey
and West (1987b), Gallant (1987, pg. 533), and Andrews and Monahan (1992) are
possibilities. With independent observations

Ω∞

ψ0   
1
n
n
∑
t  1
gt

ψˆ

gt

ψˆ


(7)

Ξ∞

ψ0   
1
n
n
∑
t  1
mt

ψˆ

mt

ψˆ
 
(8)
will provide consistent estimators, in many cases.
We have now seen how to implement the standard Hausman test when neither esti-
mator is efficient. But the above suggests two additional ways to test correct specifica-
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tion, one which is well-known, and the other which is new. For clarity, the presentation
will be done in terms of GMM estimators. Consider the omnibus estimator when both
estimators can be put in the GMM form. In this case we can define the two GMM
estimators as
ˆθ1 
 argmax
θ   Θ
s1n

θ  Zn    m1n

θ1  Zn   W 1n m1n

θ1  Zn   (9)
ˆθ2 
 argmax
θ   Θ
s2n

θ  Zn    m2n

θ2  Zn  W 2n m2n

θ2  Zn   (10)
We can define the omnibus moment condition mn

ψ

   m1n

θ1  Zn 

m2n

θ2  Zn 

ﬁ

,
and the omnibus GMM estimator
ψˆ


arg max
ψ   Θ  Θ
sn

ψ

  mn

ψ


 

W 1n 0pq
0qp W 2n


mn

ψ

 (11)
where p is the number of moment conditions that defines ˆθ1 and q is the number of
moment conditions that defines ˆθ2. That is, the omnibus estimator also has a GMM
representation. Now, since the estimators will be correlated when neither is efficient,
it is clear that the weighting matrix that defines this (equation 11) GMM estimator is
not the efficient weight matrix, even if W1n and W 2n are the efficient weight matrices for
the two separate estimators. A different Hausman test may be based on the omnibus
GMM estimator that uses the overall efficient weight matrix (the inverse of a consistent
estimator of the overall covariance of the moment conditions, in equation 6). One may
use the Wald test for the hypothesis θ1   θ2. This test should be more powerful than
the usual Hausman test, since it is based upon a more efficient estimator.
Finally, the previous test is based upon the unrestricted estimator, where the two
parameter vectors are not restricted in estimation. If we take the previous moment
condition but impose the restriction that the two estimators be equal, then we have ψ  
θ, and the moment condition becomes mn

ψ

   m1n

ψ  Zn 

m2n

ψ  Zn 

ﬁ

. This
leads to an new overidentified GMM estimator, based upon pooling the moments that
define the separate estimators to define a single estimator. Now we may apply GMM
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using the optimal weighting matrix, estimated by whatever means are appropriate.
We have overidentification, and standard results tell us that the GMM criterion test
statistic nsn

ψˆ

is asymptotically central chi-square with p

q  k degrees of freedom
when the moment conditions are correctly specified. The GMM criterion test statistic
is essentially a score test applied to the omnibus model, while the Hausman test is a
Wald test.
In this section we have defined three test statistics. The first is the standard Haus-
man test, but with the covariance between the estimators taken into account at the point
of testing, but not when estimating. This can be thought of as a Wald test applied to
an inefficient GMM estimator. We will refer to this as the H1 test. The second is the
same test, but using the covariance between the estimators to improve the efficiency of
estimation. This will be referred to as the H2 test. The final GMM criterion test with
pooled moments and the restriction imposed will be referred to as the CRIT test. The
original, uncorrected Hausman test, which is not asymptotically valid in the general
case, will be referred to as the H0 test.
The H1 and H2 tests are Wald tests applied to unrestricted GMM estimators. Burn-
side and Eichenbaum (1996) find that the true size of such Wald tests often exceeds the
nominal size, especially when a number of restrictions are tested jointly. They find that
using a covariance estimator calculated using the formulae for the unrestricted estima-
tor, but evaluated at the restricted estimator (that used for the CRIT test) can improve
the small sample performance of Wald tests. In what follows we will report results
based upon covariance estimators calculated using both the unrestricted and restricted
estimators.
Finally, a Hausman test may be based upon the entire vector of differences, or
on a sub-vector, where some of the rows of the matrix R in equation 5 are dropped.
In what follows we will present results both for the full version where equality of all
parameters is tested, and a version of the test where equality of a single parameter is
tested. To explain the notation that is used to describe the tests, an “f” means that the
full set of restrictions that all parameters are equal is tested, while an “s” means that
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a single restriction is tested. The notation “be” means that the Burnside-Eichenbaum
suggestion for estimating the covariance is used, otherwise the standard estimator for
a Wald test is used. For example, “H2(sbe)” means the H2 test of a single restriction,
with the Burnside-Eichenbaum suggestion. H0(f) is the standard Hausman test, using
all restrictions.
3 Simulations
In this section we examine two simple situations that illustrate the problems one may
encounter when using the standard Hausman test with inefficient estimators, and that
examine the performances of the alternative tests.
3.1 A linear model
Consider a linear model with heteroscedastic errors and a potentially endogenous re-
gressor, generated by random sampling from the following model:
y   0

z

ησ
 



z
η
w




  
N





 



0
0
0






 




1 ρ1 ρ2
 1 0
  1










σ  

1

z

Thus, z will be an endogenous regressor when ρ1   0. We may use w as an instrument
for z. Since the errors are heteroscedastic, the OLS estimator will not be efficient (it is
a QML estimator), and the standard Hausman will not be valid. It can be shown that
the test statistics are invariant to a scalar multiple of σ.
To investigate size, we set n   100  ρ1   0  ρ2   0  5, and we perform 10,000 repli-
cations.2 Since ρ1   0, z is exogenous. We use the OLS and IV estimators of the model
2All results in this paper were obtained using GNU Octave (www.octave.org). All data and estimation
programs needed to replicate the results in this paper are available upon request from the author.
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y   β1  β2z  ε to calculate the test statistics. The instruments used to calculate the
IV estimator are  1  w w2

. The full (“f”) tests are based upon equality of the OLS and
IV estimators of both β1and β2, while the single (“s”) tests check equality of β2, the
coefficient of the potentially endogenous regressor. Table 1 presents the results for the
various tests. We see that the standard Hausman test (H0) has serious size distortions
in both the full and single restriction versions of the test. The CRIT test performs quite
well. The H1 and H2 tests perform quite well, except for the H1(f) and H2(f) tests,
which under-reject. The “be” versions of the H1 and H2 tests all have true size close
to nominal size.
To examine power, we repeat the simulation, with everything as above but setting
ρ   0  3. The results are reported in Table 2. Of the tests that were found to have proper
size, the H2(sbe) test is the most powerful, though the H1(sbe) test is a close second.
3.2 A count data model with a latent variable
Consider a count data model with a normally distributed latent variable that is poten-
tially correlated with an observed regressor, generated by random sampling from the
following model:
 



z
η
w




  
N





 



0
0
0






 



1 ρ1 ρ2
 1 0
  1










y
 
Poisson
 λ

λ   ez   η

1  2
The two estimators used to perform the Hausman test are the Poisson QML estima-
tor that is defined assuming y
 
Poisson
 λ

where λ   exp  β1  β2z  (i.e., the latent
variable is ignored) and the nonlinear instrumental variables (NLIV) estimator sug-
gested by Mullahy (1997), which uses the residual function exp   β1  β2z  y  1 and
the instruments  1  w w2

. Again, z will be an endogenous regressor when ρ1   0, so
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the Poisson QML estimator will not be consistent in this case. The IV estimator is
consistent. Neither estimator is efficient in either case.
First we set n   500  ρ1   0  ρ2   0  5  In this case the latent variable is uncor-
related with the regressor, so both the NLS and the NLIV estimators are consistent.
We use 10,000 replications. Table 3 presents rejection frequencies for the 10%, 5%
and 1% significance levels, respectively. We see that the standard (H0) test presents
very serious size distortions in both the full and single restriction version. The CRIT
test also seriously over-rejects. The “f” versions of the H1 and H2 tests also seriously
over-reject, and the “fbe” versions over-reject, too, though not as seriously. The H1(s),
H2(s) and H2(sbe) tests all have true size almost equal to nominal size. The “be”
version slightly under-rejects, while the other two over-reject slightly.
Next, to check power, we repeat the above scenario, but setting ρ1   0  3, so that
z is endogenous. Table 4 reports the results. The H1(s) and H2(s) are more powerful
than the H2(sbe) test. This is perhaps expected, since the results on size indicate that
the H2(sbe) test is the most conservative of the three. We do not comment on the power
of the other tests, since they were found to have serious size distortions.
In summary, these simulation results show that the standard Hausman test can
suffer from serious size problems when neither of the estimators it is based upon is
efficient. The CRIT test for the overidentifying restrictions of the pooled GMM esti-
mator also can be seriously distorted. Of the tests proposed in this paper, the single
restriction tests appear to be quite reliable, especially when the Burnside-Eichenbaum
covariance estimator is used.
4 Demand for health care and insurance coverage
Much research effort has investigated the determinants of health care usage, with a
small sample of papers being Pohlmeier and Ulrich (1995); Gurmu (1997) and Deb and
Holmes (2000). Variables such as private insurance coverage or self-reported health
status may be jointly determined with variables related to usage of health care services
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(Cameron et. al., 1988; Windmeijer and Santos Silva, 1997; Vera-Hernández, 1999).
For example, if both usage and the decision to purchase private insurance are in part
determined by an unobservable personal characteristic such as health status, then there
will exist a problem of endogeneity in the estimation of the usage model, if usage
depends upon insurance status.
Currently, the most common means of estimating a model for count data while
taking into account endogeneity is apply a GMM estimator (Windmeijer and Santos
Silva, 1997; Mullahy, 1997; Terza, 1998; Vera-Hernández, 1999). Another possibility
is to estimate a bivariate model for both endogenous variables by maximum likelihood
(ML), using a sufficiently flexible bivariate density (Terza, 1998; Van Ophem, 2000,
Romeu and Vera-Hernández, 2001). This idea is incompletely developed at present,
due to the difficulties involved in finding a computationally tractable bivariate density
that is sufficiently flexible to warrant the assumption of correct specification. Under
the more traditional approach, when facing the choice between using an estimator that
ignores endogeneity and a GMM estimator that accounts for it, a Hausman test of
the type presented in this paper will be a useful tool. The modified version of the
Hausman test will be needed when the estimator that is based upon the assumption of
exogeneity cannot be assumed to be a ML estimator, perhaps because of unmodeled
latent variables or other reasons.
4.1 Data
We use the 1996 Medical Expenditure Panel Survey (MEPS) data, which contains six
different measures of annual health care usage3. These are office-based doctor visits
(OBDV), outpatient visits (OPV), emergency room visits (ERV), inpatient visits (IPV),
dental visits (DV), and number of prescription drugs taken (PRESCR). In order to
obtain a simple model that can pass specification tests, we limit the sample to people of
age between 40 and 65 years, inclusive, and we estimate separate models for men and
women. The explanatory variables are months of private insurance coverage during
3The raw data (file HC-012) is available at www.meps.ahrq.gov, and the programs used to prepare the
data, the prepared data, and the estimation routines are available from the author.
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the year (PRIV), months of public insurance coverage during the year (PUB), age
(AGE), years of schooling (EDUC), and family income (INC). All the variables with
the exception of INC are directly available. INC was constructed by summing the
incomes of all members of the family. Observations for which any family member’s
income was “hot decked” were dropped.4 There are 984 observations (men) and 1117
observations (women) for which all needed variables are available.
We do not condition on any measure of health status. The health status measures
available in the MEPS data are either perceived health status, sometimes self-reported,
sometimes reported by other family members, and objective measures that are quite
specific and that may not be good indicators of overall health. As such, health status
is treated as a purely latent variable. The fact that both health care usage and private
insurance status are likely to depend upon health status is the reason that one suspects
endogeneity of private insurance status in a model of health care usage. We assume
that public insurance status is exogenous in a model of health care usage. While there
may be some grounds for questioning this assumption, it appears to be reasonable for
this data set in light of the specification test results reported below.
Let η be a latent index of health status that has expectation equal to unity.5 We
suspect that η and PRIV may be correlated, but we assume that η is uncorrelated with
the other regressors. For each of the health care usage measures, represented as y in
the following equation6 , we assume that
E

y

PUB  PRIV  AGE  EDUC  INC  η

  exp
 β1  β2PUB  β3PRIV  β4AGE  β5EDUC  β6INC  η 
4
“Hot decking” is a term used in the MEPS documentation to describe a method of replacing missing
data with conditional or unconditional means of the variable. See the documentation for the HC-012 file,
available at www.meps.ahrq.gov, for more details.
5A restriction of this sort is necessary for identification.
6The regression coefficients are assumed to vary according to the usage measure, but this is suppressed
in the notation for readability.
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We use the Poisson QML estimator of the model
y
 
Poisson
 λ

λ   exp  β1  β2PUB  β3PRIV  β4AGE  β5EDUC  β6INC   (12)
Since much previous evidence indicates that health care services usage is overdis-
persed7 , this is almost certainly not an ML estimator, and thus is not efficient. How-
ever, when η and PRIV are uncorrelated, this estimator is consistent for the β i param-
eters, since the conditional mean is correctly specified in that case.
When η and PRIV are correlated, Mullahy’s (1997) NLIV estimator that uses the
residual function
ε  
y
λ
 1 
where λ is defined in equation 12, with appropriate instruments, is consistent. As
instruments we use all the exogenous regressors, as well as the cross products of PUB
with the variables in Z    AGE  EDUC  INC

. That is, the full set of instruments is
W  
 1 PUB Z PUB  Z  
Since PUB is rather strongly negatively correlated with PRIV (ρ    0  485

, and since
the coefficient of determination when PRIV is regressed by ordinary least squares on
the instruments, W , is R2   0  40, we conclude that the instruments are reasonably
strong. There are 8 instruments and 6 parameters to estimate.
Neither the the QML nor the NLIV estimators are efficient, which suggests that
the standard Hausman test may give misleading results. In order for the results of any
Hausman-type test to be convincing, we should have evidence that the NLIV estimator
is in fact consistent. To check the correctness of the specification of the conditional
mean and the validity of the instruments, we put the NLIV estimator in the GMM
form, and report the omnibus specification test nsn

ˆθ

where sn

ˆθ

is the GMM cri-
7Overdispersion exists when the conditional variance is greater than the conditional mean. If this is
the case, the Poisson specification is not correct.
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terion function using the optimal weighting matrix. Table 5 presents the marginal
significance level at which the null hypothesis of correct specification may be rejected,
for each of the use measures, and for men and women. In only one case do we reject
at a level below 10%. Given that this sort of test often over-rejects in finite samples
(Hansen and Heaton, 1996), we conclude that the fairly simple model seems to be an
adequate specification of the conditional mean.
When testing exogeneity of private insurance status, we hypothesize that endo-
geneity is most likely to be present when the level of use of a type of care is to a large
degree under the control of the patient. Office-based visits (OBDV) and dental visits
(DV) seem to be the two clearest cases. While the practitioner certainly can influence
the number of visits of these types, the patient also has a good degree of control, since
the patient initiates the visits. On the other hand, outpatient visits (OPV) and inpatient
visits (IPV) require a physician’s intervention for a usage event to occur. Emergency
room visits are due to accidents or unexpected illnesses that are (at least usually) se-
vere enough that immediate care is necessary, and are thus unlikely to be strongly
influenced by private insurance status. The number of prescription drugs taken (PRE-
SCR) is an unclear case, since a physician must prescribe the drugs, but the patient can
initiate visits with a number of physicians. In sum, we expect that endogeneity may
be a problem when analyzing the OBDV and DV measures of use. Private insurance
status seems unlikely to be endogenous in models for OPV, IPV and ERV. We have no
strong prior opinion in the case of PRESCR.
Tables 6 and 7 present the marginal significance levels (p-values) at which exo-
geneity of PRIV may be rejected, for all of the tests and for each of the usage vari-
ables, for men and women, respectively. The simulation results in Section 3.2, which
are for a model similar to that estimated here, suggest that the most reliable test is the
H2(sbe) tests, so those are the results we focus on for the purpose of testing exogeneity.
All of the single restriction tests are calculated using the difference of the estimated
coefficents of PRIV.
In Tables 6 and 7, the H2(sbe) test gives strong evidence that private insurance
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status is endogenous in the cases of the OBDV and PRESCR usage measures, for both
men and women. The case of DV, for men, is the only other measure for which the
H2(sbe) p-value approaches conventional levels for rejection. The other tests that were
found to work reasonably well in the simulations (the H1(s), H1(sbe), and H2(s) tests)
all give similar results, except that exogeneity is questionable in the case of IPV for
men. It is worth noting that the conventional Hausman test gives a p-value of one
in a number of cases. This is because the test statistic took on a negative value in
those cases. This occurs since the difference of the estimated covariance matrices of
the GMM and GML estimators is not necessarily positive semidefinite. None of the
different versions of the H1 and H2 tests are affected by this problem, since taking the
covariance between the estimators into account causes the overall estimated covariance
matrix to be positive semidefinite.
In summary, private insurance status appears to be endogenous for the OBDV and
PRESCR usage measures, for both men and women. This is not unexpected in the case
of OBDV, but the case of PRESCR is perhaps surprising. The unobserved factors that
lead to higher than average consumption of prescription drugs appear to be correlated
with those that lead to seeking private insurance coverage. The effect of unobserved
health status could very plausibly explain this phenomenon. The factors that lead
physicians to prescribe drugs could also be of some importance.
5 Conclusions
This paper has presented several modified versions of the Hausman test that may be
used when neither of the estimators is efficient. The standard Hausman test is not valid
in this case, as has been illustrated using simulation. The simulation results illustrate
the fact, already known in the literature (e.g. Hansen and Heaton, 1996), that the
CRIT test, while asymptotically valid, can suffer from serious size distortions. The
simulations, within their limited scope, show that the single restriction versions of the
H1 and H2 tests performs quite well. We do not attempt a broader Monte Carlo study
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simple since the number possibilities to investigate is overwhelming. When we turn
to an empirical investigation, we find that the new tests gives results that are plausible,
given prior beliefs regarding the determinants of health care visits.
An empirical result that should be highlighted is that, for health care usage, exo-
geneity seems to be a fairly innocuous assumption in certain situations. When this is
the case, univariate maximum likelihood methods, which have been extensively devel-
oped in recent research, may be safely used, with the resulting efficiency. On the other
hand, the results strongly indicate that endogeneity is a problem for certain usage mea-
sures. In these cases GMM estimation seems to be the best alternative, at least until the
multivariate ML approach is better developed. In this study, public insurance coverage
is available, and provides a strong instrument for private insurance coverage. In other
studies, for example, that of Vera-Hernández (1999), where all individuals have public
coverage, such an instrument is not available, and the GMM estimates suffer from im-
precision. This is the sort of situation that might motivate additional work on flexible
multivariate densities, in order to deal with endogeneity while retaining efficiency.
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Table 1: Frequency of Rejections, Linear Model, True Null Hypothesis
10% 5% 1%
H0(f) 0.0622 0.0431 0.0229
H0(s) 0.2467 0.1798 0.0993
CRIT 0.1064 0.0489 0.0081
H1(f) 0.0435 0.0157 0.0014
H1(fbe) 0.0970 0.0435 0.0071
H1(s) 0.0843 0.0354 0.0032
H1(sbe) 0.1049 0.0494 0.0087
H2(f) 0.0282 0.0117 0.0012
H2(fbe) 0.0970 0.0435 0.0071
H2(s) 0.0990 0.0435 0.0065
H2(sbe) 0.1122 0.0580 0.0108
Table 2: Frequency of Rejections, Linear Model, False Null Hypothesis
10% 5% 1%
H0(f) 0.1166 0.0834 0.0442
H0(s) 0.4356 0.3631 0.2439
CRIT 0.3123 0.1957 0.0552
H1(f) 0.1995 0.1017 0.0190
H1(fbe) 0.2992 0.1841 0.0481
H1(s) 0.3577 0.2170 0.0483
H1(sbe) 0.3881 0.2606 0.0851
H2(f) 0.1852 0.0974 0.0213
H2(fbe) 0.2992 0.1841 0.0481
H2(s) 0.3607 0.2290 0.0567
H2(sbe) 0.3890 0.2635 0.0907
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Table 3: Frequency of Rejections, Count Model, True Null Hypothesis
10% 5% 1%
H0(f) 0.0946 0.0766 0.0567
H0(s) 0.2094 0.1479 0.0743
CRIT 0.1911 0.1168 0.0412
H1(f) 0.2096 0.1438 0.0685
H1(fbe) 0.1319 0.0781 0.0326
H1(s) 0.1168 0.0617 0.0166
H1(sbe) 0.1164 0.0634 0.0208
H2(f) 0.1911 0.1277 0.0576
H2(fbe) 0.1095 0.0611 0.0236
H2(s) 0.1108 0.0565 0.0158
H2(sbe) 0.0913 0.0422 0.0103
Table 4: Frequency of Rejections, Count Model, False Null Hypothesis
10% 5% 1%
H0(f) 0.3495 0.3141 0.2560
H0(s) 0.4692 0.4087 0.3021
CRIT 0.6820 0.5664 0.3438
H1(f) 0.8236 0.7698 0.6499
H1(fbe) 0.4280 0.2761 0.0902
H1(s) 0.5663 0.4610 0.2588
H1(sbe) 0.3870 0.2409 0.0724
H2(f) 0.8312 0.7739 0.6520
H2(fbe) 0.4038 0.2464 0.0743
H2(s) 0.5653 0.4558 0.2569
H2(sbe) 0.3897 0.2312 0.0525
Table 5: p-value of GMM Specification Test, NLIV Estimator
Men Women
OBDV 0.758 0.738
OPV 0.419 0.161
IPV 0.119 0.802
ERV 0.934 0.073
DV 0.347 0.374
PRESCR 0.731 0.588
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Table 6: Specification test p-values, Men
OBDV OPV IPV ERV DV PRESCR
H0(f) 1.000 1.000 1.000 0.988 0.000 1.000
H0(s) 0.000 0.666 0.005 0.411 0.003 0.000
CRIT 0.000 0.935 0.008 0.669 0.058 0.000
H1(f) 0.000 0.956 0.002 0.678 0.000 0.000
H1(fbe) 0.000 0.743 0.000 0.000 0.000 0.000
H1(s) 0.000 0.721 0.008 0.487 0.001 0.000
H1(sbe) 0.005 0.736 0.221 0.542 0.174 0.031
H2(f) 0.000 0.980 0.001 0.470 0.000 0.000
H2(fbe) 0.000 0.415 0.000 0.000 0.000 0.000
H2(s) 0.000 0.728 0.008 0.494 0.001 0.000
H2(sbe) 0.006 0.741 0.260 0.550 0.154 0.015
Table 7: Specification test p-values, Women
OBDV OPV IPV ERV DV PRESCR
H0(f) 0.000 1.000 1.000 0.892 0.956 0.000
H0(s) 0.000 1.000 0.468 0.493 0.846 0.000
CRIT 0.000 0.001 0.530 0.036 0.187 0.001
H1(f) 0.000 0.003 0.636 0.383 0.432 0.000
H1(fbe) 0.000 0.000 0.462 0.000 0.070 0.000
H1(s) 0.000 0.149 0.590 0.517 0.855 0.000
H1(sbe) 0.043 0.134 0.684 0.533 0.852 0.048
H2(f) 0.000 0.902 0.501 0.042 0.313 0.000
H2(fbe) 0.000 0.775 0.007 0.000 0.054 0.000
H2(s) 0.000 0.938 0.618 0.527 0.848 0.000
H2(sbe) 0.046 0.945 0.700 0.541 0.844 0.047
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